CVRx, Inc. Selling, General and Administrative Expense
CVRx, Inc. (CVRX) reported Selling, General and Administrative Expense of $23.62 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-06
- CVRx, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $23.62M, a 1.11% increase year-over-year.
- CVRx, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $21.96M, a 3.42% increase year-over-year.
- CVRx, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $22.01M, a 8.74% increase year-over-year.
- CVRx, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $21.88M, a 1.12% increase year-over-year.
- CVRx, Inc. selling, general and administrative expense for fiscal 2025 was $88.47M, a 3.11% decline from fiscal 2024.
- CVRx, Inc. selling, general and administrative expense for fiscal 2024 was $91.32M, a 41.56% increase from fiscal 2023.
- CVRx, Inc. selling, general and administrative expense for fiscal 2023 was $64.51M, a 28.90% increase from fiscal 2022.
- CVRx, Inc. selling, general and administrative expense for fiscal 2022 was $50.05M, a 79.61% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $23.62M 10-Q · filed 2026-08-06 | $45.58M 10-Q · filed 2026-08-06 | $67.58M derived: sum of 3 quarters · filed 2026-08-06 | $89.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $21.96M 10-Q · filed 2026-05-12 | $43.97M derived: sum of 2 quarters · filed 2026-05-12 | $65.84M derived: sum of 3 quarters · filed 2026-05-12 | $89.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $22.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $43.88M derived: sum of 2 quarters · filed 2026-02-13 | $67.24M derived: sum of 3 quarters · filed 2026-08-06 | $88.47M 10-K · filed 2026-02-13 |
| 2025-09-30 | $21.88M 10-Q · filed 2025-11-06 | $45.23M derived: sum of 2 quarters · filed 2026-08-06 | $66.46M 10-Q · filed 2025-11-06 | $86.70M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $23.36M 10-Q · filed 2026-08-06 | $44.59M 10-Q · filed 2026-08-06 | $64.83M derived: sum of 3 quarters · filed 2026-08-06 | $86.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $21.23M 10-Q · filed 2026-05-12 | $41.47M derived: sum of 2 quarters · filed 2026-05-12 | $63.10M derived: sum of 3 quarters · filed 2026-05-12 | $84.22M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $20.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $41.87M derived: sum of 2 quarters · filed 2026-02-13 | $62.99M derived: sum of 3 quarters · filed 2026-02-13 | $91.32M 10-K · filed 2026-02-13 |
| 2024-09-30 | $21.63M 10-Q · filed 2025-11-06 | $42.75M derived: sum of 2 quarters · filed 2025-11-06 | $71.08M 10-Q · filed 2025-11-06 | $88.08M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $21.11M 10-Q · filed 2025-08-05 | $49.45M 10-Q · filed 2025-08-05 | $66.45M derived: sum of 3 quarters · filed 2025-08-05 | $82.10M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $28.33M 10-Q · filed 2025-05-09 | $45.34M derived: sum of 2 quarters · filed 2025-05-09 | $60.99M derived: sum of 3 quarters · filed 2025-05-09 | $77.44M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $32.66M derived: sum of 2 quarters · filed 2025-02-18 | $49.11M derived: sum of 3 quarters · filed 2025-02-18 | $64.51M 10-K · filed 2025-02-18 |
| 2023-09-30 | $15.65M 10-Q · filed 2024-11-01 | $32.11M derived: sum of 2 quarters · filed 2024-11-01 | $47.50M 10-Q · filed 2024-11-01 | $61.60M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $16.45M 10-Q · filed 2024-08-02 | $31.85M 10-Q · filed 2024-08-02 | $45.95M derived: sum of 3 quarters · filed 2024-08-02 | $58.63M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $15.40M 10-Q · filed 2024-05-10 | $29.50M derived: sum of 2 quarters · filed 2024-05-10 | $42.18M derived: sum of 3 quarters · filed 2024-05-10 | $54.66M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $14.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $26.78M derived: sum of 2 quarters · filed 2024-02-09 | $39.27M derived: sum of 3 quarters · filed 2024-02-09 | $50.05M 10-K · filed 2024-02-09 |
| 2022-09-30 | $12.68M 10-Q · filed 2023-10-31 | $25.17M derived: sum of 2 quarters · filed 2023-10-31 | $35.95M 10-Q · filed 2023-10-31 | $45.61M derived: sum of 4 quarters · filed 2023-10-31 |
| 2022-06-30 | $12.49M 10-Q · filed 2023-08-03 | $23.27M 10-Q · filed 2023-08-03 | $32.93M derived: sum of 3 quarters · filed 2023-08-03 | $41.04M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $10.78M 10-Q · filed 2023-05-11 | $20.44M derived: sum of 2 quarters · filed 2023-05-11 | $28.55M derived: sum of 3 quarters · filed 2023-05-11 | $34.18M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $9.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $17.78M derived: sum of 2 quarters · filed 2023-02-10 | $23.40M derived: sum of 3 quarters · filed 2023-02-10 | $27.86M 10-K · filed 2023-02-10 |
| 2021-09-30 | $8.11M 10-Q · filed 2022-11-04 | $13.74M derived: sum of 2 quarters · filed 2022-11-04 | $18.20M 10-Q · filed 2022-11-04 | $21.46M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $5.63M 10-Q · filed 2022-08-01 | $10.09M 10-Q · filed 2022-08-01 | $13.35M derived: sum of 3 quarters · filed 2022-08-01 | $15.68M derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | $4.46M 10-Q · filed 2022-05-02 | $7.72M derived: sum of 2 quarters · filed 2022-05-02 | $10.05M derived: sum of 3 quarters · filed 2022-05-02 | $11.88M derived: sum of 4 quarters · filed 2022-05-02 |
| 2020-12-31 | $3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $5.59M derived: sum of 2 quarters · filed 2022-02-22 | $7.42M derived: sum of 3 quarters · filed 2022-02-22 | $9.72M 10-K · filed 2022-02-22 |
| 2020-09-30 | $2.33M 10-Q · filed 2021-11-08 | $4.16M derived: sum of 2 quarters · filed 2021-11-08 | $6.46M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $1.83M 10-Q · filed 2021-08-09 | $4.13M 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |